Medtronic (MDT) stock in focus as the company wins FDA nod to integrate its MiniMed 780G insulin pump with Abbott's (ABT) ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with type 2 diabetes in the U.S., and allowing it to c | ...

The global Network Point-of-Care Glucose Testing Market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.8% ...

Afon Technology is pioneering advancements in diabetes care with GlucowearTM, the world’s first non-invasive, real-time, blood glucose monitor ...

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers.

“Existen muchas enfermedades crónicas relacionadas con la diabetes o con comorbilidades ... Stelo, lanzado el año pasado, es ...

The US Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management.

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing ...

Abbott Launches Next-Gen FreeStyle Libre® 2 Plus with Continuous Glucose Readings Every Minute & Optional Alarms ...

Digital health tools could help detect and possibly prevent chronic long-term condition in childhood cancer survivors, ...

Tracking my glucose in real time revealed surprising spikes, hidden dips, and what my body’s really doing behind the scenes.